Skip to main content
SpringerLink
Log in

B7-mediated costimulation can either provoke or prevent clinical manifestations of experimental allergic encephalomyelitis

  • Published:
Immunologic Research Aims and scope Submit manuscript

Abstract

T-cell activation requires signalling provided by ligation of the T-cell receptor for antigen (TCR) and a second antigen (Ag) nonspecific signal, known as costimulation. The B7 receptors, CD80 (B7-1) and CD86 (B7-2), on the Ag-presenting cell (APC), interact with T-cell CD28 or CTLA-4 to deliver a costimulatory signal, which is particularly important for Th1 activation. Experimental allergic encephalomyelitis (EAE) is an autoimmune disorder, induced by Th1 cells directed against myelin antigens that provides an in vivo model for studying the role of B7-mediated costimulation in the induction of a pathological immune response. Using a soluble fusion protein ligand for the B7 receptors, as well as specific monoclonal antibodies specific for either CD80 or CD86, it has been demonstrated that B7 costimulation plays a prominent role in determining clinical disease outcome in EAE. Here we review recent data indicating that a paradoxical exacerbation of disease as well as the expected amelioration of disease can occur with costimulatory receptor blockade.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Zamvil SS, Steinman L: The T lymphocyte in experimental allergic encephalomyelitis. Annu Rev Immunol 1990;8:579.

    Article  PubMed  CAS  Google Scholar 

  2. Martin R, McFarland HF, McFarlin DE: Immunological aspects of demyelinating diseases. Annu Rev Immunol 1992;10:153.

    Article  PubMed  CAS  Google Scholar 

  3. Raine CS: Biology of disease: Analysis of autoimmune demyelination: its impact upon multiple sclerosis. Lab Invest 1984;50:608.

    PubMed  CAS  Google Scholar 

  4. Arnason BG: Relevance of experimental allergic encephalomyelitis to multiple sclerosis. Neurol Clin 1983;1:765.

    PubMed  CAS  Google Scholar 

  5. Lublin FD, Knobler RL, Kalman B, Goldhaber M, Marini J, Perrault M, D'Imperio C, Joseph J, Alkan SS, Korngold R: Monoclonal anti-gamma interferon antibodies enhance experimental allergic encephalomyelitis. Autoimmunity 1993;16:267.

    Article  PubMed  CAS  Google Scholar 

  6. Raine CS: The Dale E. McFarlin Memorial Lecture: The immunology of the multiple sclerosis lesion. Ann Neurol 1994;36(suppl):S61.

    Article  Google Scholar 

  7. Schwartz RH: A cell culture model for T lymphocyte clonal anergy. Science 1990;248:1349.

    Article  PubMed  CAS  Google Scholar 

  8. Harding FA, McArthur JG, Gross JA, Raulet DH, Allison JP: CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 1992;356:607.

    Article  PubMed  CAS  Google Scholar 

  9. Gimmi CD, Freeman GJ, Gribben JG, Gray G, Nadler LM: Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc Natl Acad Sci USA 1993;90:6586.

    Article  PubMed  CAS  Google Scholar 

  10. Sloan-Lancaster J, Shaw AS, Rothbard JB, Allen PM: Partial T cell signaling: Altered phospho-zeta and lack of zap70 recruitment in APL-induced T cell anergy. Cell 1994;79:913.

    Article  PubMed  CAS  Google Scholar 

  11. Selmaj K, Raine CS, Cross AH: Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann Neurol 1991;30:694.

    Article  PubMed  CAS  Google Scholar 

  12. Weaver CT, Unanue ER: The costimulatory function of antigen-presenting cells. Immunol Today 1990; 11:49.

    Article  PubMed  CAS  Google Scholar 

  13. Lenschow DJ, Zeng Y, Thistlethwaite JR, Montag A, Brady W, Gibson MG, Linsley PS, Bluestone JA: Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 1992;257:789.

    Article  PubMed  CAS  Google Scholar 

  14. Linsley PS, Wallace PM, Johnson J, Gibson MG, Greene JL, Ledbetter JA, Singh C, Trepper MA: Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 1992;257:792.

    Article  PubMed  CAS  Google Scholar 

  15. Lin H, Bolling SF, Linsley PS, Wei RQ, Gordon D, Thompson CB, Turka LA: Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J Exp Med 1993; 178:1801.

    Article  PubMed  CAS  Google Scholar 

  16. Finck BK, Linsley PS, Wofsy D: Treatment of murine lupus with CTLA4Ig. Science 1994;265:1225.

    Article  PubMed  CAS  Google Scholar 

  17. Shahinian A, Pfeffer K, Lee KP, Kundig TM, Kishihara K, Wakeham A, Kawai K, Ohashi PS, Thompson CB, Mak TW: Differential T cell costimulatory requirements in CD28-deficient mice. Science 1993;261:609.

    Article  PubMed  CAS  Google Scholar 

  18. June CH, Ledbetter JA, Linsley PS, Thompson CB: Role of the CD28 receptor in T-cell activation. Immunol Today 1990;11:211.

    Article  PubMed  CAS  Google Scholar 

  19. Walunas TL, Lenschow DJ, Bakker CY, Linsley PS, Freeman GJ, Green JM, Thompson CB, Bluestone JA: CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994;1:405.

    Article  PubMed  CAS  Google Scholar 

  20. Damle NK, Klussman K, Leytze G, Myrdal S, Aruffo A, Ledbetter JA, Linsley PS: Costimulation of T lymphocytes with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B7. J Immunol 1994;152:2686.

    PubMed  CAS  Google Scholar 

  21. McCarron R, McFarlin DE: Adoptively transferred experimental autoimmune encephalomyelitis in SJL/J, PL/J, and (SJL/J×PL/J)F1 mice. Influence of I-A haplotype on encephalitogenic epitope of myelin basic protein. J Immunol 1988;141:1143.

    PubMed  CAS  Google Scholar 

  22. Linsley PS, Greene JI, Brady W, Bajorath J, Ledbetter JA, Peach R: Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1994;1:793.

    Article  PubMed  CAS  Google Scholar 

  23. Razi Wolf Z, Freeman GJ, Galvin F, Benacerraf B, Nadler L, Reiser H: Expression and function of the murine B7 antigen, the major costimulatory molecule expressed by peritoneal exudate cells. Proc Natl Acad Sci USA 1992;89:4210.

    Article  PubMed  CAS  Google Scholar 

  24. Hathcock KS, Laszlo G, Dickler HB, Bradshaw J, Linsley P, Hodes RJ: Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science 1993;262:905.

    Article  PubMed  CAS  Google Scholar 

  25. Boussiotis VA, Freeman GJ, Gribben JG, Daley J, Gray G, Nadler LM: Activated human B lymphocytes express three CTLA4 counter-receptors that costimulate T-cell activation. Proc Natl Acad Sci USA 1993;90:11059.

    Article  PubMed  CAS  Google Scholar 

  26. Goodman RE, Nestle F, Naidu YM, Green JM, Thompson CB, Nickoloff BJ, Turka LA: Keratinocyte-derived T cell costimulation induces preferential production of IL-2 and IL-4 but not IFN-gamma. J Immunol 1994;152:5189.

    PubMed  CAS  Google Scholar 

  27. Sagerstrom CG, Kerr EM, Allison JP, Davis MM: Activation and differentiation requirements of primary T cells in vitro. Proc Natl Acad Sci USA 1993;90:8987.

    Article  PubMed  CAS  Google Scholar 

  28. Croft M, Bradley LM, Swain SL: Naive versus memory CD4 T cell response to antigen: Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. J Immunol 1994;152:2675.

    PubMed  CAS  Google Scholar 

  29. McKnight AJ, Perez VL, Shea CM, Gray GS, Abbas AK: Costimulator dependence of lymphokine secretion by naive and activated CD4+ T lymphocytes from TCR transgenic mice. J Immunol 1994;152:5220.

    PubMed  CAS  Google Scholar 

  30. Guckel B, Berek C, Lutz M, Alevogt P, Schirrmacher V, Kyewski A: Anti-CD2 antibodies induce T cell unresponsiveness in vivo. J Exp Med 1991;174:957.

    Article  PubMed  CAS  Google Scholar 

  31. Isobe M, Yagita H, Okumura K, Ihara A: Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science 1992;255:1125.

    Article  PubMed  CAS  Google Scholar 

  32. Liu Y, Jones B, Aruffo A, Sullivan KM, Linsley PS, Janeway CA Jr: Heat-stable antigen is a costimulatory molecule for CD4 T cell growth. J Exp Med 1992;175:437.

    Article  PubMed  CAS  Google Scholar 

  33. Perrin PJ, Scott D, Quigley L, Albert PS, Feder O, Gray GS, Abe R, June CH, Racke MK: Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis. J Immunol 1995;154:1481.

    PubMed  CAS  Google Scholar 

  34. Cocks BG, Chang C-CJ, Carballido JM, Yssel H, de Vries JE, Aversa G: A novel receptor involved in T-cell activation. Nature 1995;376:260.

    Article  PubMed  CAS  Google Scholar 

  35. Tough DF, Sprent J: Turnover of naive- and memory-phenotype T cells. J Exp Med 1994;179:1127.

    Article  PubMed  CAS  Google Scholar 

  36. Sprent J: The thymus and T-cell tolerance. Ann NY Acad Sci 1993;681:5.

    Article  PubMed  CAS  Google Scholar 

  37. Racke MK, Bonomo A, Scott DE, Cannella B, Levine A, Raine CS, Shevach EM, Rocken M: Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med 1994;180:1961.

    Article  PubMed  CAS  Google Scholar 

  38. Karpus WJ, Peterson JD, Miller SD: Anergy in vivo: Down-regulation of antigen-specific CD4+ Th1 but not Th2 cytokine responses. Int Immunol 1994;6:721.

    Article  PubMed  CAS  Google Scholar 

  39. Peterson JD, Karpus WJ, Clatch RJ, Miller SD: Split tolerance of Th1 and Th2 cells in tolerance to Theiler's murine encephalomyelitis virus. Eur J Immunol 1993;23:46.

    Article  PubMed  CAS  Google Scholar 

  40. Sayegh MH, Akalin E, Hancock WW, Russell ME, Carpenter CB, Linsley PS, Turka LA: CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med 1995; 181:1869.

    Article  PubMed  CAS  Google Scholar 

  41. Sethna MP, Parijs LV, Sharpe AH, Abbas AK, Freeman GJ: A negative regulatory function of B7 revealed in B7-1 transgenic mice. Immunity 1994;1:415.

    Article  PubMed  CAS  Google Scholar 

  42. Ronchese F, Hausmann B, Hubele S, Lane P: Mice transgenic for a soluble form of murine CTLA-4 show enhanced expansion of antigen-specific CD4+ T cells and defective antibody production in vivo. J Exp Med 1994;179:809.

    Article  PubMed  CAS  Google Scholar 

  43. Kuchroo V, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N, Glimcher LH: B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995;80:707.

    Article  PubMed  CAS  Google Scholar 

  44. Lenschow DJ, Ho SC, Satter H, Rhee L, Gray G, Nabavi N, Herold KC, Bluestone JA: Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med 1995;181:1145.

    Article  PubMed  CAS  Google Scholar 

  45. Powell MB, Mitchell D, Lederman J, Buckmeier J, Zamvil SS, Graham M, Ruddle NH, Steinman L: Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Int Immunol 1990;2:539.

    Article  PubMed  CAS  Google Scholar 

  46. Jemison LM, Williams SK, Lublin FD, Knobler RL, Korngold R: Interferon-gamma-inducible endothelial cell class II major histocompatibility complex expression correlates with strain- and site-specific susceptibility to experimental allergic encephalomyelitis. J Neuroimmunol 1993;47:15.

    Article  PubMed  CAS  Google Scholar 

  47. Racke MK, Scott DE, Quigley L, Gray GS, Abe R, June CH, Perrin PJ: Distinct roles for B7-1 (CD80) and B7-2 (CD86) in the initiation of experimental allergic encephalomyelitis. J Clin Invest 1995; accepted for publication.

Download references

Author information

Authors and Affiliations

  1. Immune Cell Biology Program, Naval Medical Research Institute, Mail Stop 06, 20889-5607, Bethesda, MD, (USA)

    Peter J. Perrin & Carl H. June

  2. Food and Drug Administration, Bethesda, Md., USA

    Dorothy Scott

  3. Department of Neurology, School of Medicine, Washington University, St. Louis, Mo., USA

    Michael K. Racke

Authors
  1. Peter J. Perrin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dorothy Scott
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Carl H. June
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michael K. Racke
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Perrin, P.J., Scott, D., June, C.H. et al. B7-mediated costimulation can either provoke or prevent clinical manifestations of experimental allergic encephalomyelitis. Immunol Res 14, 189–199 (1995). https://doi.org/10.1007/BF02918216

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02918216

Key Words

Search

Navigation